Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 May;61(5):1276–1285. doi: 10.1172/JCI109044

3,3′-Diiodothyronine Production, a Major Pathway of Peripheral Iodothyronine Metabolism in Man

Laurence A Gavin 1,2, Margaret E Hammond 1,2, James N Castle 1,2, Ralph R Cavalieri 1,2
PMCID: PMC372649  PMID: 659591

Abstract

3,3′-Diiodothyronine (3,3′-T2) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3′-T2 relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT4) (n = 5) or triiodothyronine replacement (HT3) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3′-T2 in whole serum was developed. Serum 3,3′-T2 concentrations were (mean ± SD) 6.0±1.0 ng/100 ml in 13 normal subjects, 9.0±4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7±1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3′-T2 was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T4, in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T4-binding globulin. The 3,3′-T2 CR was assessed from data acquired from the 125I-3,3′-T2 constant infusion technique. The 3,3′-T2 PR was calculated from CR and serum concentration of 3,3′-T2 determined by radio-immunoassay. In the HT4 subjects the 3,3′-T2 CR averaged 840±377 liters/day and 3,3′-T2 PR 33.9±12.5 μg/day. These results were not significantly different from those in the control group: 3,3′-T2 CR 628±218 liters/day and 3,3′-T2 PR 39.8±19.8 μg/day (all corrected to 70 kg body wt). In addition to 3,3′-T2 PR, T3, and reverse triiodothyronine (rT3) PR were determined in three of the HT4 subjects. In each case studied, the 3,3′-T2 PR was close to the combined triiodothyronine (T3 + rT3) PR. The mean molar ratio of T2 PR/(T3 + rT3) PR was 1.08±0.10. The results obtained in the HT4 subjects indicate that the production of 3,3′-T2 is a major route of T4 metabolism. The combined studies of 3,3′-T2, T3 and rT3 PR in the HT4 subjects indicate that both T3 and rT3 are major precursors of 3,3′-T2. In the HT3 subjects, the conversion of T3 to 3,3′-T2, determined as the molar ratio of 3,3′-T2 PR to T3 PR, ranged from 0.36 to 0.92, providing further evidence that T3 is a precursor of 3,3′-T2. From the close agreement between the mean values for 3,3′-T2 PR in the euthyroid and HT4 group it is concluded that most, if not all of the 3,3′-T2 produced in normal humans is derived by extrathyroidal conversion from T3 and rT3.

Full text

PDF
1276

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abreau C., Vagenakis A., Azizi F., Portnay G., Braverman L. A single method for measuring total thyroxine and free thyroxine index in serum. J Nucl Med. 1973 Oct;14(10):740–746. [PubMed] [Google Scholar]
  2. Burger A., Sakoloff C. Serum 3,3'-L-diiodothyronine, a direct radioimmunoassay in human serum: method and clinical results. J Clin Endocrinol Metab. 1977 Sep;45(3):384–391. doi: 10.1210/jcem-45-3-384. [DOI] [PubMed] [Google Scholar]
  3. Burman K. D., Strum D., Dimond R. C., Djuh Y. Y., Wright F. D., Earll J. M., Wartofsky L. A radioimmunoassay for 3,3'-L-diiodothyronine (3,3'T2). J Clin Endocrinol Metab. 1977 Aug;45(2):339–352. doi: 10.1210/jcem-45-2-339. [DOI] [PubMed] [Google Scholar]
  4. Chopra I. J. A study of extrathyroidal conversion of thyroxine (T4) to 3,3',5-triiodothyronine (T3) in vitro. Endocrinology. 1977 Aug;101(2):453–463. doi: 10.1210/endo-101-2-453. [DOI] [PubMed] [Google Scholar]
  5. Chopra I. J. An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man. J Clin Invest. 1976 Jul;58(1):32–40. doi: 10.1172/JCI108456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FLOCK E. V., BOLLMAN J. L., GRINDLAY J. H. 3,3' Diiodothyronine, a metabolite of 3,5,3' triiodothyronine. Proc Staff Meet Mayo Clin. 1960 Feb 17;35:75–81. [PubMed] [Google Scholar]
  7. FLOCK E. V., BOLLMAN J. L., GRINDLAY J. H. Conjugates of triodothyronine and its metabolites. Endocrinology. 1960 Sep;67:419–429. doi: 10.1210/endo-67-3-419. [DOI] [PubMed] [Google Scholar]
  8. FLOCK E. V., DAVID C., STOBIE G. H., OWEN C. A., Jr 3,3',5'-TRIIODOTHYRONINE AND 3,3'-DIIODOTHYRONINE: PARTIALLY DEIODINATED INTERMEDIATES IN THE METABOLISM OF THE THYROID HORMONES. Endocrinology. 1963 Oct;73:442–455. doi: 10.1210/endo-73-4-442. [DOI] [PubMed] [Google Scholar]
  9. Flock E. V., Owen C. A., Jr Metabolism of thyroid hormones and some derivatives in isolated, perfused rat liver. Am J Physiol. 1965 Nov;209(5):1039–1045. doi: 10.1152/ajplegacy.1965.209.5.1039. [DOI] [PubMed] [Google Scholar]
  10. GEMMILL C. L. Metabolic activity of 3, 3'-diiodothyronine and 3, 3'-diiodo-5-bromothyronine. Am J Physiol. 1956 Jul;186(1):1–5. doi: 10.1152/ajplegacy.1956.186.1.1. [DOI] [PubMed] [Google Scholar]
  11. Gavin L., Castle J., McMahon F., Martin P., Hammond M., Cavalieri R. R. Extrathyroidal conversion of thyroxine to 3,3',5'-triiodothyronine (reverse-T3) and to 3,5,3'-triiodothyronine (T3) in humans. J Clin Endocrinol Metab. 1977 Apr;44(4):733–742. doi: 10.1210/jcem-44-4-733. [DOI] [PubMed] [Google Scholar]
  12. Gharib H., Ryan R. J., Mayberry W. E., Hockert T. Radioimmunoassay for triiodothyronine (T 3 ): I. Affinity and specificity of the antibody for T 3 . J Clin Endocrinol Metab. 1971 Sep;33(3):509–516. doi: 10.1210/jcem-33-3-509. [DOI] [PubMed] [Google Scholar]
  13. Goldfine I. D., Smith G. J., Simons C. G., Ingbar S. H., Jorgensen E. C. Activities of thyroid hormones and related compounds in an in vitro thymocyte assay. J Biol Chem. 1976 Jul 25;251(14):4233–4238. [PubMed] [Google Scholar]
  14. Green W. L. Separation of iodo compounds in serum by chromatography on Sephadex columns. J Chromatogr. 1972 Oct 5;72(1):83–91. doi: 10.1016/0021-9673(72)80010-4. [DOI] [PubMed] [Google Scholar]
  15. JOUAN P., MICHEL R., ROCHE J. Sur la présence d'acide 3:5:3'-triiodothyroacétique et de 3:3'-diiodothyronine dans le muscle aprés administration de L-3:5:3'-triiodothyronine au rat. Bull Soc Chim Biol (Paris) 1956 Sep 4;38(5-6):941–950. [PubMed] [Google Scholar]
  16. JOUAN P., MICHEL R., ROCHE J., WOLF W. The recovery of 3:5:3' -triiodothyroacetic acid and 3:3' -diiodothyronine from rat kidney after injection of 3:5:3' triiodothyronine. Endocrinology. 1956 Oct;59(4):425–432. doi: 10.1210/endo-59-4-425. [DOI] [PubMed] [Google Scholar]
  17. Larsen P. R. Direct immunoassay of triiodothyronine in human serum. J Clin Invest. 1972 Aug;51(8):1939–1949. doi: 10.1172/JCI107000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MONEY W. L., KUMAOKA S., RAWSON R. W., KROC R. L. Comparative effects of thyroxine analogues in experimental animals. Ann N Y Acad Sci. 1960 Apr 23;86:512–544. doi: 10.1111/j.1749-6632.1960.tb42827.x. [DOI] [PubMed] [Google Scholar]
  19. Nicoloff J. T., Low J. C., Dussault J. H., Fisher D. A. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. J Clin Invest. 1972 Mar;51(3):473–483. doi: 10.1172/JCI106835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. ROCHE J., MICHEL R., NUNEZ J., ETLING N. Sur le métabolisme de la DL-3:3'-diiodothyronine et sur le rôle de celle-ci en tant qu'hormone thyroïdienne. C R Seances Soc Biol Fil. 1955 Jun;149(11-12):1215–1219. [PubMed] [Google Scholar]
  21. ROCHE J., MICHEL R., NUNEZ J., JACQUEMIN C. On the metabolism of 3,3'-diiodothyronine and 3,3',5'-triiodothyronine. Endocrinology. 1959 Sep;65:402–407. doi: 10.1210/endo-65-3-402. [DOI] [PubMed] [Google Scholar]
  22. ROCHE J., MICHEL R., WOLF W., NUNEZ J. Sur deux nouveaux constituants hormonaux du corps thyroïde, la 3:3' -diiodothyronine et la 3:3':5' -triiodothyronine. Biochim Biophys Acta. 1956 Feb;19(2):308–317. doi: 10.1016/0006-3002(56)90433-4. [DOI] [PubMed] [Google Scholar]
  23. SHEN N. H., KATZMAN M. B., FRANCIS F. E., KINSELLA R. A., Jr Determination of pregnanolone, pregnanediol, and pregnanetriol in urine. J Lab Clin Med. 1963 Jan;61:174–182. [PubMed] [Google Scholar]
  24. STANBURY J. B., MORRIS M. L. The metabolism of 3:3'-diiodothyronine in man. J Clin Endocrinol Metab. 1957 Nov;17(11):1324–1331. doi: 10.1210/jcem-17-11-1324. [DOI] [PubMed] [Google Scholar]
  25. STASILLI N. R., KROC R. L., MELTZER R. I. Antigoitrogenic and calorigenic activities of thyroxine analogues in rats. Endocrinology. 1959 Jan;64(1):62–82. doi: 10.1210/endo-64-1-62. [DOI] [PubMed] [Google Scholar]
  26. Snyder S. M., Cavalieri R. R., Goldfine I. D., Ingbar S. H., Jorgensen E. C. Binding of thyroid hormones and their analogues to thyroxine-binding globulin in human serum. J Biol Chem. 1976 Nov 10;251(21):6489–6494. [PubMed] [Google Scholar]
  27. Sorimachi K., Robbins J. Metabolism of thyroid hormones by cultured monkey hepatocarcinoma cells. Nonphenolic ring dieodination and sulfation. J Biol Chem. 1977 Jul 10;252(13):4458–4463. [PubMed] [Google Scholar]
  28. TAIT J. F. REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO. J Clin Endocrinol Metab. 1963 Dec;23:1285–1297. doi: 10.1210/jcem-23-12-1285. [DOI] [PubMed] [Google Scholar]
  29. Taurog A., Riesco G., Larsen P. R. Formation of 3,3'-diiodothyronine and 3',5',3-triiodothyronine (reverse T3) in thyroid glands of rats and in enzymatically iodinated thyroglobulin. Endocrinology. 1976 Jul;99(1):281–290. doi: 10.1210/endo-99-1-281. [DOI] [PubMed] [Google Scholar]
  30. Wu S. Y., Chopra I. J., Nakamura Y., Solomon D. H., Bennett L. R. A radioimmunoassay for measurement of 3,3'-L-diiodothyronine (T2). J Clin Endocrinol Metab. 1976 Sep;43(3):682–685. doi: 10.1210/jcem-43-3-682. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES